logo

KREBSBIO vs VIYASH: Stock Comparison

KREBS BIOCHEMICALS & IND vs VIYASH SCIENTIFICUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

VIYASH SCIENTIFIC is the larger company by market capitalisation. KREBS BIOCHEMICALS & IND shows a lower P/E and faster revenue growth, while VIYASH SCIENTIFIC shows a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KREBSBIO leads 3; VIYASH leads 4 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KREBSBIOVIYASH

Valuation lens

What price are you paying?

Market CapContext only
₹125 Cr
₹9,199 Cr
P/E RatioKREBSBIO has the lower reading
0x ✓
49.82x
P/B RatioKREBSBIO has the lower reading
0x ✓
3.12x
EPSVIYASH has the higher reading
₹-1.15
₹1.51 ✓
Book ValueContext only
—
₹71.3
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIYASH is the larger company
₹9,199 Cr vs ₹125 Cr
P/E Ratio
KREBSBIO has a lower P/E
0x vs 49.82x
P/B Ratio
KREBSBIO has a lower P/B
0x vs 3.12x
EPS
VIYASH has higher earnings per share
₹1.51 vs ₹-1.15
Revenue Growth (TTM YoY)
KREBSBIO has faster revenue growth
11.6% vs 0%
ROCE
VIYASH has a higher ROCE
8.17% vs -15.89%
Net Margin
VIYASH has a higher net margin
6.57% vs -71.35%
Operating Margin
VIYASH has a higher operating margin
12.23% vs -41.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKREBSBIOVIYASH
SectorHealthcare—
IndustryPharmaceuticals—

Price

MetricKREBSBIOVIYASH
Live Price₹57.48₹207.99
Day Change2.53%-2.62%
Volume3,57021.17 L
52-Week High₹76.85₹298
52-Week Low₹38.33₹178.13
Distance from 52W High-25.2%-30.2%

Valuation

MetricKREBSBIOVIYASH
Market Cap₹125 Cr₹9,199 Cr
P/E Ratio0x49.82x
P/B Ratio0x3.12x
EPS₹-1.15₹1.51
Book Value—₹71.3
Dividend Yield0%0%

Growth

MetricKREBSBIOVIYASH
Revenue Growth (TTM YoY)11.6%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricKREBSBIOVIYASH
ROE—7.21%
ROCE-15.89%8.17%
Net Margin-71.35%6.57%
Operating Margin-41.49%12.23%
Debt to Equity—0.14x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricKREBSBIOVIYASH
Promoter Holding72.74%0%
FII Holding0.5%2.6%▼ 1.9 pp
DII Holding0%8.3%▲ 4.55 pp
Public Holding26.76%39.76%▲ 9.42 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KREBS BIOCHEMICALS & IND and VIYASH SCIENTIFIC.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.